Merck & Co., Inc. - 19 Dec 2024 Form 3 Insider Report for Personalis, Inc. (PSNL)

Role
10%+ Owner
Signature
/s/ Kelly Grez, Corporate Secretary
Issuer symbol
PSNL
Transactions as of
19 Dec 2024
Net transactions value
$0
Form type
3
Filing time
23 Dec 2024, 06:00:18 UTC
Previous filing
11 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PSNL Common Stock, $0.0001 par value per share 14,044,943 19 Dec 2024 See footnotes F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On December 19, 2024, Merck Sharp & Dohme LLC ("MSD") entered into an Investment Agreement with Personalis, Inc. (the "Company"), pursuant to which MSD purchased from the Company 14,044,943 shares of the Company's common stock, par value $0.0001 per share, at a price per share of $3.56.
F2 MSD is a direct wholly-owned subsidiary of Merck & Co., Inc. ("Merck", and together with MSD, the "Reporting Persons").
F3 Each of the Reporting Persons declare that the filing of this Form 3 shall not be construed as an admission that the Reporting Persons are the beneficial owners of any securities reported in this Form 3.